ApprovalTrail

Drug · DIN 02216728

FLURESS

No: no longer authorized

The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.

Status Cancelled Post Market since March 1, 2021; first marketed December 18, 1996.
Drug Identification Number (DIN)
02216728
Company (DIN owner)
Akorn IncLake Forest, Illinois, United States
Schedule
Ethical
Dosage form
Solution
Route
Ophthalmic
Therapeutic class (ATC)
Fluorescein, combinations S01JA51
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
FLUORESCEIN SODIUM0.25 %
BENOXINATE HYDROCHLORIDE0.4 %